The fair value estimate for Cytokinetics has shifted from US$79.56 to US$92.94, signaling a fresh look at what the shares might be worth in updated models. That change lines up with recent analyst ...

While Mondelez International has lagged the broader market over the past year, analysts maintain a cautiously constructive ...